GT Biopharma, Inc. (GTBP) vs Vaxxinity, Inc. (VAXX)
- GT Biopharma, Inc. GTBP 7.03 −4.48%
- Vaxxinity, Inc. VAXX 0.00 NaN
GT Biopharma, Inc. and Vaxxinity, Inc. are both Biotechnology companies. GT Biopharma, Inc. and Vaxxinity, Inc. are of similar size ($15.5M and $15.2M). Across the 10 metrics below, Vaxxinity, Inc. leads on 6 and GT Biopharma, Inc. on 4.
Valuation
Profitability
| Metric | GTBP | VAXX | Biotechnology median |
|---|---|---|---|
| Gross margin | 41.67% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 102.03% | (150.65%) | (56.36%) |
| Return on assets | (176.27%) | (75.55%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack